Yan Ji

15PUBLICATIONS
43CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsMolecular targetsTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jul 13, 2026
Ligelizumab Immunogenicity and Impact on Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety in Patients With Chronic Spontaneous Urticaria.

|Jun 23, 2026
Quantitative Pharmacology Justifying Ribociclib Dose in Early Breast Cancer.

|Mar 28, 2026
Physiologically-Based Pharmacokinetics of Ribociclib Drug-Drug Interactions and Organ Impairment Pharmacokinetics in Early Breast Cancer.

Yan Ji, Felix Huth, Craig Wang

|Oct 30, 2025
Challenges in Extrapolating Healthy Volunteer Pharmacokinetics to Oncology Populations: Advocating for a Holistic Perspective.

Yan Ji, Romain Sechaud, Abhijit Chakraborty

|Aug 23, 2025
Model-Informed Drug Development for Ligelizumab in Patients With Chronic Spontaneous Urticaria.

Andrzej Bienczak, Aurelie Gautier, Eva Hua

|Mar 02, 2024
Utility and impact of quantitative pharmacology on dose selection and clinical development of immuno-oncology therapy.

Yan Ji, Sherwin K B Sy

Pageof 3

Frequent Collaborators

2 joint publications

Manmath Patekar

2 joint publications

Eva Hua

2 joint publications

Sherwin K B Sy

1 joint publications

Ralph Woessner